ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,174Medicare Part D Prescriptions Filled, Including Refills

Rank: 177 out of 1006

$803K Total Retail Price of All Prescriptions

Rank: 79 out of 1006

521 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 521 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 521 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 6,807 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$98 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 305 281 1 2
SIMVASTATIN 232 211 2 1
ATORVASTATIN CALCIUM 221 210 3 5
FUROSEMIDE 170 164 4 6
OMEPRAZOLE 166 136 5 9
HYDROCHLOROTHIAZIDE 161 149 6 11
ZOLPIDEM TARTRATE 158 130 7 14
AMLODIPINE BESYLATE 152 152 8 4
HYDROCODONE-ACETAMINOPHEN 146 99 S3 9 25
CRESTOR 126 101 10 18
ALENDRONATE SODIUM 125 125 11 29
SYNTHROID 120 97 12 42
METOPROLOL TARTRATE 116 112 13 7
PREDNISONE 115 110 14 33
WARFARIN SODIUM 113 110 15 8
DONEPEZIL HCL 105 105 16 17
ESCITALOPRAM OXALATE 100 79 17 27
NAMENDA 100 100 17 34
LISINOPRIL 80 80 19 3
LOSARTAN POTASSIUM 76 73 20 22
BYSTOLIC 74 74 21 84
DIGOXIN 73 73 22 52
TAMSULOSIN HCL 73 70 22 23
CARVEDILOL 72 53 24 36
ATENOLOL 72 70 24 13
METOPROLOL SUCCINATE 71 71 26 12
ALLOPURINOL 69 65 27 31
CITALOPRAM HBR 68 62 28 24
CELEBREX 66 52 29 90
CYMBALTA 66 40 29 41
DIOVAN 64 64 31 16
LEVOFLOXACIN 64 56 31 96
DOXAZOSIN MESYLATE 63 63 33 87
TRAZODONE HCL 63 35 33 21
SPIRIVA 62 62 35 48
SERTRALINE HCL 61 58 36 19
LYRICA 58 32 37 115
ADVAIR DISKUS 56 48 38 37
KLOR-CON M20 56 56 38 70
JANUMET 55 53 40 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.